journal article·2017-10

Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells

Jianhong Yang, Wenshuang Wu, Jiaolin Wen, Haoyu Ye, Hong Luo, Peng Bai, Minghai Tang, Fang Wang, Li Zheng, Shengyong Yang, Weimin Li, Aihua Peng, Li Yang, Li Wan, Lijuan Chen

Biomaterials· Volume 141
Publisher page

Abstract

Honokiol (HK), a natural chemical isolated from Mangnolia officinalis, has shown antitumorigenic activities when used to treat a variety of tumor cell lines. The mechanism of honokiol activity when used to treat gefitinib-sensitive and gefitinib-resistant non-small cell lung cancer (NSCLC) requires elucidation. Here, the presence of liposomal honokiol (LHK) induced apoptotic and antitumor activities in four xenograft models generated using NSCLC cell lines such as HCC827 (gefitinib-sensitive) and H1975 (gefitinib-resistant). Mechanistic studies revealed that LHK inhibited the Akt and Erk1/2, both EGFR signaling cascades effectors, by promoting degradation of HSP90 client proteins (HCP), including wild-type or mutant EGFR, Akt and C-Raf. Molecular biology assays showed that LHK induced HCP degradation through a lysosomal pathway, rather than the canonical proteasome protein degradation pathway. As a result of misfolded protein accumulation, LHK induced endoplasmic reticulum (ER) stress and autophagy. Inhibition of ER stress (with 4-phenylbutyrate) or autophagy (with small interfering RNA) reduced LHK-induced HCP degradations. Additionally, LHK induced autophagy showed a protective role for cancer cell as inhibition of autophagy in vitro and in vivo by autophagosome degradation inhibitors could promote the anticancer activity of LHK. LHK has been approved by the China Food and Drug Administration for first-in-human clinical trials in NSCLC. The current study will guide the design of future LHK clinical trials.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Magnolia and Illicium research · Autophagy in Disease and Therapy · Ginseng Biological Effects and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
2. Targeting the dynamic HSP90 complex in cancer10.1038/nrc2887 ↗
3. An acetylation site in the middle domain of Hsp90 regulates chaperone function10.1016/j.molcel.2006.12.008 ↗
4. HDAC6 inhibition enhances 17-AAG–mediated abrogation of hsp90 chaperone function in human leukemia cells10.1182/blood-2008-03-143644 ↗
5. Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance10.1158/0008-5472.CAN-07-5428 ↗
6. Hsp90 inhibition overcomes HGF-triggering resistance to EGFR-TKIs in EGFR-mutant lung cancer by decreasing client protein expression and angiogenesis
7. Autophagy in health and disease: a double-edged sword10.1126/science.1099993 ↗
8. Endoplasmic reticulum stress triggers autophagy10.1074/jbc.M607007200 ↗
9. Autophagy eliminates a specific species of misfolded procollagen and plays a protective role in cell survival against ER stress10.4161/auto.5.8.10168 ↗
10. The ubiquitin–proteasome pathway: on protein death and cell life10.1093/emboj/17.24.7151 ↗
11. Targeting multiple signal transduction pathways through inhibition of Hsp9010.1007/s00109-004-0549-9 ↗
12. Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy10.1083/jcb.200810183 ↗
13. Xiao. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IκB kinase (IKK)10.1038/sj.cr.7310109 ↗
14. Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography10.1016/j.chroma.2006.09.098 ↗
15. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt310.1038/ncomms7656 ↗
16. A natural-product switch for a dynamic protein interface10.1002/anie.201403773 ↗
17. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells
18. Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells10.3892/ol.2013.1548 ↗
19. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells10.1002/cncr.22551 ↗
20. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo10.1074/jbc.M302967200 ↗
21. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation10.1016/j.bcp.2005.08.011 ↗
22. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
23. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis10.1182/blood-2005-01-0346 ↗
24. Honokiol mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast and prostate carcinoma without impacting T cell function10.1097/CJI.0b013e3181a8efe6 ↗
25. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells10.1002/pros.22837 ↗
26. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model10.1002/ijc.24244 ↗
27. Isogambogenic acid induces apoptosis-independent autophagic cell death in human non-small-cell lung carcinoma cells10.1038/srep07697 ↗
28. Aggrephagy: selective disposal of protein aggregates by macroautophagy10.1155/2012/736905 ↗
29. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy10.1007/s00726-007-0615-z ↗
30. Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha10.1128/MCB.22.24.8506-8513.2002 ↗
31. Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells10.1182/blood-2006-11-053728 ↗
32. Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma10.1158/1535-7163.MCT-12-0782 ↗
33. The mammalian unfolded protein response10.1146/annurev.biochem.73.011303.074134 ↗
34. Methods for monitoring autophagy from yeast to human10.4161/auto.3678 ↗
35. p62 at the crossroads of autophagy, apoptosis, and cancer10.1016/j.cell.2009.05.023 ↗
36. Yang · 2009
37. ER stress triggers apoptosis by activating BH3-only protein Bim10.1016/j.cell.2007.04.027 ↗
38. Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis10.1074/jbc.M111.309104 ↗
39. Update on Hsp90 inhibitors in clinical trial10.2174/156802609789895728 ↗
40. Honokiol from Magnolia spp. induces G1 arrest via disruption of EGFR stability through repressing HDAC6 deacetylated Hsp90 function in lung cancer cells10.1016/j.jff.2015.03.018 ↗
41. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo10.4161/epi.23078 ↗
42. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors10.1158/1078-0432.CCR-10-0333 ↗
43. Intracellular protein catabolism and its control during nutrient deprivation and supply10.1146/annurev.nu.07.070187.002543 ↗
44. Role of proteasomes in the degradation of short-lived proteins in human fibroblasts under various growth conditions10.1016/S1357-2725(02)00382-5 ↗
45. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates10.1242/jcs.114926 ↗
46. Turnover of C99 is controlled by a crosstalk between ERAD and ubiquitin-independent lysosomal degradation in human neuroglioma cells10.1371/journal.pone.0083096 ↗
47. Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma10.1016/j.bcp.2009.04.001 ↗
48. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response10.1158/1078-0432.CCR-11-1789 ↗